Hepion Pharmaceuticals, Inc. (HEPA)
NASDAQ: HEPA · IEX Real-Time Price · USD
2.490
-0.010 (-0.40%)
At close: Mar 28, 2024, 4:00 PM
2.520
+0.030 (1.20%)
After-hours: Mar 28, 2024, 6:35 PM EDT

Hepion Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020201920182017201620152014
Selling, General & Admin
10.3510.018.154.5973.365.795.561.36
Research & Development
33.2720.4123.187.597.1615.028.40.31
Other Operating Expenses
1.8700000000
Operating Expenses
45.4930.420.157.7714.5910.5220.8113.961.67
Operating Income
-45.49-30.4-20.15-7.77-14.59-10.52-20.81-13.96-1.67
Interest Expense / Income
0.010.010.030.550.340000.01
Other Expense / Income
-0.412.310.15-0.38-4.95-1.06-3.818.233.6
Pretax Income
-45.08-32.72-20.32-7.95-9.99-9.46-17-22.19-5.28
Income Tax
-2.8800.03-0.91-0.54-1.95000
Net Income
-42.2-32.72-20.35-7.04-9.45-7.51-17-22.19-5.28
Preferred Dividends
3.1400.015.448.450000
Net Income Common
-45.34-32.72-20.36-12.48-17.9-7.51-17-22.19-5.28
Shares Outstanding (Basic)
440000000
Shares Outstanding (Diluted)
440000000
Shares Change
8.45%626.31%373.65%1011.18%33.00%186.13%24.41%69.76%-
EPS (Basic)
-11.80-9.40-42.00-122.20-1947.00-1092.00-7056.01-11424.01-4592.01
EPS (Diluted)
-11.80-9.40-42.00-122.20-1947.00-1092.00-7056.01-11424.01-4592.01
Free Cash Flow
-34.98-31.35-16.25-7.62-15.65-8.21-16.56-9.76-1.38
Free Cash Flow Per Share
-9.18-8.92-33.58-74.55-1701.68-1187.50-6854.73-5022.63-1204.87
EBITDA
-45-32.63-20.26-7.36-9.63-9.45-16.98-22.18-5.27
Depreciation & Amortization
0.080.090.030.030.020.010.020.020
EBIT
-45.07-32.71-20.29-7.39-9.65-9.46-17-22.19-5.27
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).